TIFFANY KUHLMEYER: Open Payments
NPI 1346684248 · FREEPORT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,227 in 68 payments from 13 companies in 2025. Trend: 2023 $905 · 2024 $868 · 2025 $1,227
Food & beverage: $1,227
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $248 |
| AstraZeneca Pharmaceuticals LP | 8 | $185 |
| Novo Nordisk Inc | 9 | $155 |
| GlaxoSmithKline, LLC. | 8 | $151 |
| Amgen Inc. | 7 | $106 |
| E.R. Squibb & Sons, L.L.C. | 4 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $90 |
| Exact Sciences Corporation | 3 | $59 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47 |
| Cranial Technologies, Inc | 2 | $38 |
Products named: NURTEC ODT, TRELEGY ELLIPTA, ELIQUIS, JARDIANCE, FARXIGA, Rybelsus, OTEZLA, EVENITY.
Industry payments across IL — which companies pay providers there.
